Leverage CBRE’s industry leading life sciences platform to access the deepest and most aggressive pool of investment capital for an array of investment opportunities within Maryland’s BioTech Corridor.
Total Activity in 2021
Active assignments 2022
We See Every Deal
Q1 2022 Maryland Life Sciences Report
Read our Q1 report highlighting how a historic 2021 set the stage for a prolific start to the new year — where demand continues to outpace supply.Read Report
Get Quarterly Insights
You'll get access to the best opportunities and our boots-on-the-ground local insights.
Life Sciences Insights & Research
- Brief | Intelligent Investment
April 21, 2022
Although a costly proposition, investors are realizing strong returns on newly built life sciences properties or those that are converted from other uses.
- Report | Adaptive Spaces
Driven by biotechnology and other advancements, the U.S. life sciences industry continues to shatter records for employment and venture capital funding.
- Report | Intelligent Investment
Demand for office space will bounce back as more workers return to the office and occupiers take advantage of favorable market conditions.
We provide the life sciences industry solutions that maximize facility and investment performance across labs, manufacturing space and critical environments.
We're Here. Let's Get Started.
Our team is here – working hand in hand with the industry leaders fueling the rapid Life Sciences sector growth in Maryland.
- Industry leading market intelligence within an opaque asset class
- Real time insight gleaned from our unrivaled work with pharmaceutical, biotech, genomic, contract research and contract manufacturing organizations
- Technical expertise and innovative sustainable operation of highly critical research and manufacturing environments
We connect capital with opportunity by sourcing all portions of the capital stack for Maryland's most sought-after projects. Our market leading activity gives us unique perspective to help our clients make informed decisions.
- Assisting investors and developers in the monetization of their owned assets
- Structuring equity including co-GP, preferred, and LP capital for new development
- Providing innovative financing solutions driven by distinct subject matter expertise
No longer emerging, it’s here: 3 key factors driving record growth in Maryland’s life sciences market
March 11, 2022
The biotechnology industry is booming in the U.S., creating a hot market for laboratories and other specialty properties.
- Press Release
January 6, 2022
Horizon Therapeutics plc announced today that it has signed a long-term, full-building lease with Alexandria Real Estate Equities, Inc. to be the first tenant at the Alexandria Center®...
- Press Release
January 3, 2022
CBRE arranged the recent sale of three office/flex properties to Thor Equities for $45 million. The properties are located at 20, 30 and 50 West Gude Drive in R...
- Press Release
August 2, 2021
Lantian Development, a full-service real estate investment and development company headquartered in Bethesda, Maryland, completed the sale of its Shady Grove Bi...